Bipolar Disorder (Manic depression) is categorized by recurrent-shifts in the mood/temper and is a manic-depressive disorder hindering the routine life of an individual.
The American Psychiatric Association categorizes Bipolar disorder into four major types of bipolar disorder: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipolar disorder due to another medical or substance abuse disorder.
Bipolar disorder affects about 45 million people worldwide, says WHO.
DelveInsight’s ‘Bipolar disorder Market Insight and Forecast – 2030’ report delivers an in-depth understanding of the Bipolar Disorder, historical and forecasted epidemiology as well as the Bipolar Disorder market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan, for the study period 2017-30.
The Bipolar Disorder market report proffers a complete view of epidemiological analysis – historical and forecasted, diagnosis tactics, present treatment régime, forthcoming novel therapies, and unmet needs along with drivers and barriers present in the Bipolar Disorder market.
Bipolar Disorder Market: Disease Understanding and Therapies available
The DelveInsight Bipolar Disorder market report gives a detailed understanding of the Bipolar Disorder by including particulars such as disease description, symptoms, causes, pathophysiology, diagnosis and treatment.
The market report offers insights into historical and 11-year forecasted Bipolar Disorder patient pool and forecasted trend for 7MM countries. It helps to identify current and forecasted Bipolar market trends by exploring numerous kinds of literature and studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool, with incidence and prevalence and their trends along with assumptions undertaken.
The report covers a thorough view of the conventional as well as present treatment approaches for Bipolar Disorder, providing treatment algorithms and guidelines in the United States, EU5, and Japan.
Bipolar Disorder Market: Marketed, and Upcoming Drugs
FDA-approved agents for the acute treatment of bipolar depression include Olanzapine-fluoxetine combination, Lurasidone, and Quetiapine.
Other off-label therapies present in the Bipolar disorder market are Anticonvulsants (such as Divalproex and lamotrigine), olanzapine monotherapy, and Lithium and lamotrigine combined therapy.
The Bipolar Disorder market report covers detailed picture of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The report helps in providing a better understanding of clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
Bipolar Disorder Market landscape
The Bipolar Disorder market outlook proffers a detailed comprehension of the historic, current, and forecasted Bipolar Disorder market trends by scrutinizing the impact of current therapies on the Bipolar Disorder market, unmet needs, Bipolar market drivers and barriers and demand of better expertise.
The Bipolar Disorder market report covers each marketed drug and late-stage pipeline therapy with their cost, inclusion and exclusion criteria’s, mechanism of action, therapy compliance rate, a growing need in the market, patient pool, expected launch year, competitive analysis, brand value, their impact on the market and view of the key opinion leaders.
Key Companies and Drugs driving Bipolar disorder market forward are Lundbeck and Otsuka Pharmaceutical (Brexpiprazole), Intra-Cellular Therapies (Lumateperone (ITI-007)), Sage Therapeutics (Sage-217) and several others.
According to DelveInsight, Bipolar Disorder market in 7MM is expected to shift positively in the study period 2017-2030.
Bipolar Disorder Report Highlights
- Dynamic Bipolar Disorder market trends
- Healthcare spending fuelling Bipolar Disorder Market
- Collaborations, mergers, and acquisitions in Market
- Challenges poised and opportunities present influencing Bipolar Disorder Market
- R&D driving Market
- Novel therapies and drugs in Bipolar Disorder pipeline
- Major players involved impacting Bipolar Disorder market
- In-depth analysis of the pipeline products (Phase III and Phase II), comparative analysis with detailed clinical profiles, key cross-competition, launch date along with product development activities
Table of Contents
1. Key Insights
2. Executive Summary of Bipolar Disorder
3. Competitive Intelligence Analysis for Bipolar Disorder
4. Bipolar Disorder: Market Overview at a Glance
5. Bipolar Disorder: Disease Background and Overview
6. Patient Journey
7. Bipolar Disorder Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Bipolar Disorder Treatment
11. Marketed Products
12. Emerging Therapies
13. Bipolar Disorder: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Bipolar Disorder
17. KOL Views
18. Market Drivers
19. Market Barriers
21. DelveInsight Capabilities
DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for
Browse through our vast repository from here.
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States